{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":31,"n_cols":5,"rows_kept":31,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[16,2,16,3],[17,2,17,3],[20,2,20,3],[20,4,20,5],[21,2,21,3],[21,4,21,5],[22,2,22,3],[22,4,22,5],[23,2,23,3],[24,2,24,3],[25,2,25,3],[27,2,27,3],[28,2,28,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910838365203321"]
[null,null,"Autore",null,"Clifton Bruno J"]
[null,null,"Titolo",null,"Family and Identity in the Book of Judges / Bruno J. Clifton"]
[null,null,"Pubbl/distr/stampa",null,"Paderborn, : Brill | Schöningh, 2021"]
[null,null,"ISBN",null,"3-657-79193-0"]
[null,null,"Edizione",null,"[1st ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (237 pages)"]
[null,null,"Collana",null,"Studies in Cultural Contexts of the Bible ; 7"]
[null,null,"Soggetti",null,"Ethnicity"]
[{"$nulls":4},"nationalism"]
[{"$nulls":4},"Israel"]
[{"$nulls":4},"Bible"]
[{"$nulls":4},"history"]
[{"$nulls":4},"literature"]
[{"$nulls":4},"hospitality"]
[{"$nulls":4},"anthropology"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Sommario/riassunto","Bruno J. Clifton examines Israel's family dynamics and identity politics in the dramatic narratives of Judges in an interdisciplinary study that brings socio-anthropological research into dialogue with the history and culture of ancient Israel. This monograph discusses the social experiences and interactions through which people in Israel might have viewed their place in the world. Institutions such as hospitality, marriage and community leadership are examined and the ethnicity, culture, social landscape, family life, and literature of ancient Israel are explored with a view to determining what impact the understanding of identity has on the interpretation of the stories in the Book of Judges."]
[null,"2.","Record Nr.",null,"UNINA9910557512703321"]
[null,null,"Autore",null,"Kumar Krishan"]
[null,null,"Titolo",null,"Radiolabeled Compounds for Diagnosis and Treatment of Cancer"]
[null,null,"Pubbl/distr/stampa",null,"Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021"]
[null,null,"Descrizione fisica",null,"1 online resource (262 p.)"]
[null,null,"Soggetti",null,"Chemistry"]
[{"$nulls":4},"Research and information: general"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Sommario/riassunto","Radiopharmaceuticals are used in the diagnosis and treatment of various diseases, especially cancer. In general, radiopharmaceuticals are either salts of radionuclides or radionuclides bound to biologically active molecules, drugs, or cells. Tremendous progress has been made in discovering, developing, and commercializing numerous radiopharmaceuticals for the imaging and therapy of cancer. Significant research is ongoing in academia and the pharmaceutical industry to develop more novel radiolabeled compounds as potential radiopharmaceuticals for unmet needs. This Special Issue aims to focus on all aspects of the design, characterization, evaluation, and development of novel radiolabeled compounds for the diagnosis and treatment of cancer and the application of new radiochemistry and methodologies for the development of novel radiolabeled compounds. Outstanding contributions presented in this Special Issue will significantly add to the field of radiopharmaceuticals."]